Vitalhub Corp. (TSE:VHI - Free Report) - Equities researchers at Cormark decreased their FY2025 earnings per share estimates for shares of Vitalhub in a research note issued to investors on Friday, June 20th. Cormark analyst G. Fairweather now expects that the company will post earnings of $0.12 per share for the year, down from their previous estimate of $0.16. The consensus estimate for Vitalhub's current full-year earnings is $0.23 per share. Cormark also issued estimates for Vitalhub's FY2027 earnings at $0.41 EPS.
A number of other analysts have also recently commented on VHI. National Bankshares set a C$14.00 price target on Vitalhub and gave the stock an "outperform" rating in a research report on Tuesday, June 10th. National Bank Financial raised Vitalhub to a "strong-buy" rating in a research report on Monday, June 9th. TD Securities boosted their price target on Vitalhub from C$13.00 to C$14.00 and gave the stock a "buy" rating in a research report on Monday, March 31st. Raymond James Financial boosted their price target on Vitalhub from C$13.50 to C$14.00 and gave the stock an "outperform" rating in a research report on Friday. Finally, Scotiabank boosted their price target on Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research report on Friday. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of C$13.25.
Check Out Our Latest Stock Analysis on Vitalhub
Vitalhub Trading Down 1.0%
Vitalhub stock traded down C$0.11 during trading hours on Monday, hitting C$11.04. 83,726 shares of the stock traded hands, compared to its average volume of 127,233. The firm's 50-day moving average price is C$10.62 and its two-hundred day moving average price is C$10.61. Vitalhub has a one year low of C$6.74 and a one year high of C$12.34. The company has a market cap of C$597.18 million, a PE ratio of 179.56, a PEG ratio of 1.18 and a beta of 1.26.
Insider Buying and Selling
In other news, Director Francis Nelson Shen purchased 25,000 shares of the stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of C$10.23 per share, with a total value of C$255,750.00. 18.57% of the stock is owned by company insiders.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
